8329TCM-B Thermally Conductive Epoxy Adhesive
Total Page:16
File Type:pdf, Size:1020Kb
8329TCM-B Thermally Conductive Epoxy Adhesive (Part B) MG Chemicals UK Limited Version No: A-2.00 Issue Date:13/05/2021 Safety data sheet according to REACH Regulation (EC) No 1907/2006, as amended by UK REACH Regulations SI 2019/758 Revision Date: 13/05/2021 L.REACH.GB.EN SECTION 1 Identification of the substance / mixture and of the company / undertaking 1.1. Product Identifier Product name 8329TCM-B Synonyms SDS Code: 8329TCM-B; 8329TCM-6ML, 8329TCM-50ML, 8329TCM-200ML | UFI:CWE0-V0FF-V008-JEUV Proper shipping name Other means of identification Thermally Conductive Epoxy Adhesive (Part B) 1.2. Relevant identified uses of the substance or mixture and uses advised against Relevant identified uses Thermally conductive adhesive for bonding and thermal management Uses advised against Not Applicable 1.3. Details of the supplier of the safety data sheet Registered company name MG Chemicals UK Limited MG Chemicals (Head office) Heame House, 23 Bilston Street, Sedgely Dudley DY3 1JA United Address 9347 - 193 Street Surrey V4N 4E7 British Columbia Canada Kingdom Telephone +(44) 1663 362888 +(1) 800-201-8822 Fax Not Available +(1) 800-708-9888 Website Not Available www.mgchemicals.com Email [email protected] [email protected] 1.4. Emergency telephone number Association / Organisation Verisk 3E (Access code: 335388) Emergency telephone +(44) 20 35147487 numbers Other emergency telephone +(0) 800 680 0425 numbers SECTION 2 Hazards identification 2.1. Classification of the substance or mixture Classification according to H314 - Skin Corrosion/Irritation Category 1B, H373 - Specific target organ toxicity - repeated exposure Category 2, H361 - Reproductive Toxicity regulation (EC) No 1272/2008 Category 2, H317 - Skin Sensitizer Category 1, H410 - Chronic Aquatic Hazard Category 1 [CLP] and amendments [1] Legend: 1. Classified by Chemwatch; 2. Classification drawn from Regulation (EU) No 1272/2008 - Annex VI 2.2. Label elements Hazard pictogram(s) Signal word Danger Hazard statement(s) H314 Causes severe skin burns and eye damage. H373 May cause damage to organs through prolonged or repeated exposure. (Liver, Nervous system) (Oral, Inhalation) H361 Suspected of damaging fertility or the unborn child. H317 May cause an allergic skin reaction. H410 Very toxic to aquatic life with long lasting effects. Supplementary statement(s) Page 1 continued... Page 2 of 25 8329TCM-B Thermally Conductive Epoxy Adhesive (Part B) Not Applicable Precautionary statement(s) Prevention P201 Obtain special instructions before use. P260 Do not breathe dust/fume. P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P273 Avoid release to the environment. P272 Contaminated work clothing should not be allowed out of the workplace. Precautionary statement(s) Response P301+P330+P331 IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. P303+P361+P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water [or shower]. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308+P313 IF exposed or concerned: Get medical advice/ attention. P310 Immediately call a POISON CENTER/doctor/physician/first aider. P302+P352 IF ON SKIN: Wash with plenty of water and soap. P363 Wash contaminated clothing before reuse. P333+P313 If skin irritation or rash occurs: Get medical advice/attention. P362+P364 Take off contaminated clothing and wash it before reuse. P391 Collect spillage. P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Precautionary statement(s) Storage P405 Store locked up. Precautionary statement(s) Disposal P501 Dispose of contents/container to authorised hazardous or special waste collection point in accordance with any local regulation. 2.3. Other hazards Inhalation and/or ingestion may produce health damage*. Limited evidence of a carcinogenic effect*. Possible respiratory sensitizer*. nonylphenol Listed in the European Chemicals Agency (ECHA) Candidate List of Substances of Very High Concern for Authorisation nonylphenol Listed in the Europe Regulation (EC) No 1907/2006 - Annex XVII (Restrictions may apply) nonylphenol Listed in the Europe Regulation (EU) 2018/1881 Specific Requirements for Endocrine Disruptors SECTION 3 Composition / information on ingredients 3.1.Substances See 'Composition on ingredients' in Section 3.2 3.2.Mixtures 1.CAS No Nanoform 2.EC No Classification according to regulation (EC) No 1272/2008 %[weight] Name Particle 3.Index No [CLP] and amendments Characteristics 4.REACH No 1.1344-28-1. 2.215-691-6 35-45 aluminium oxide EUH210 [1] Not Available 3.Not Available 4.Not Available 1.1314-13-2 2.215-222-5 Chronic Aquatic Hazard Category 1, Acute Aquatic Hazard 30-40 zinc oxide Not Available 3.030-013-00-7 Category 1; H410, H400 [2] 4.Not Available 1.25154-52-3 Acute Toxicity (Oral) Category 4, Skin Corrosion/Irritation 2.246-672-0 nonylphenol Category 1B, Reproductive Toxicity Category 2, Acute Aquatic 10 Not Available 3.601-053-00-8 [e] Hazard Category 1, Chronic Aquatic Hazard Category 1; H302, 4.Not Available H314, H361fd, H400, H410 [2] Corrosive to Metals Category 1, Acute Toxicity (Oral) Category 4, 1.1761-71-3 Skin Corrosion/Irritation Category 1A, Chronic Aquatic Hazard 2.217-168-8 Category 2, Skin Sensitizer Category 1, Specific target organ 2 4,4'-methylenebis(cyclohexylamine) Not Available 3.Not Available toxicity - repeated exposure Category 2, Serious Eye 4.Not Available Damage/Eye Irritation Category 1; H290, H302, H314, H411, H317, H373, H318 [1] Continued... Page 3 of 25 8329TCM-B Thermally Conductive Epoxy Adhesive (Part B) 1.CAS No Nanoform 2.EC No Classification according to regulation (EC) No 1272/2008 %[weight] Name Particle 3.Index No [CLP] and amendments Characteristics 4.REACH No 1.112-24-3 Acute Toxicity (Dermal) Category 4, Chronic Aquatic Hazard 2.203-950-6 0.5 triethylenetetramine Category 3, Skin Sensitizer Category 1, Skin Corrosion/Irritation Not Available 3.612-059-00-5 Category 1B; H312, H412, H317, H314 [2] 4.Not Available 1.1333-86-4 2.215-609-9|435-640-3|422-130-0 0.4 carbon black Carcinogenicity Category 2; H351 [1] Not Available 3.Not Available 4.Not Available Legend: 1. Classified by Chemwatch; 2. Classification drawn from Regulation (EU) No 1272/2008 - Annex VI; 3. Classification drawn from C&L; * EU IOELVs available; [e] Substance identified as having endocrine disrupting properties SECTION 4 First aid measures 4.1. Description of first aid measures If this product comes in contact with the eyes: Immediately hold eyelids apart and flush the eye continuously with running water. Ensure complete irrigation of the eye by keeping eyelids apart and away from eye and moving the eyelids by occasionally lifting the upper Eye Contact and lower lids. Continue flushing until advised to stop by the Poisons Information Centre or a doctor, or for at least 15 minutes. Transport to hospital or doctor without delay. Removal of contact lenses after an eye injury should only be undertaken by skilled personnel. If skin or hair contact occurs: Immediately flush body and clothes with large amounts of water, using safety shower if available. Skin Contact Quickly remove all contaminated clothing, including footwear. Wash skin and hair with running water. Continue flushing with water until advised to stop by the Poisons Information Centre. Transport to hospital, or doctor. If fumes or combustion products are inhaled remove from contaminated area. Lay patient down. Keep warm and rested. Prostheses such as false teeth, which may block airway, should be removed, where possible, prior to initiating first aid procedures. Apply artificial respiration if not breathing, preferably with a demand valve resuscitator, bag-valve mask device, or pocket mask as trained. Perform CPR if necessary. Transport to hospital, or doctor, without delay. Inhalation of vapours or aerosols (mists, fumes) may cause lung oedema. Inhalation Corrosive substances may cause lung damage (e.g. lung oedema, fluid in the lungs). As this reaction may be delayed up to 24 hours after exposure, affected individuals need complete rest (preferably in semi-recumbent posture) and must be kept under medical observation even if no symptoms are (yet) manifested. Before any such manifestation, the administration of a spray containing a dexamethasone derivative or beclomethasone derivative may be considered. This must definitely be left to a doctor or person authorised by him/her. (ICSC13719) IF SWALLOWED, REFER FOR MEDICAL ATTENTION, WHERE POSSIBLE, WITHOUT DELAY. For advice, contact a Poisons Information Centre or a doctor. Urgent hospital treatment is likely to be needed. In the mean time, qualified first-aid personnel should treat the patient following observation and employing supportive measures as indicated by the patient's condition. If the services of a medical officer or medical doctor are readily available, the patient should be placed in his/her care and a copy of the SDS should be provided. Further action will be the responsibility of the medical specialist. If medical attention is not available on the worksite or surroundings send the patient to a hospital together with a copy of the SDS. Ingestion Where medical attention is not immediately available or where the patient is more than 15 minutes from a hospital or unless instructed otherwise: INDUCE vomiting with fingers down the back of the throat, ONLY IF CONSCIOUS. Lean patient forward or place on left side (head-down position, if possible) to maintain open airway and prevent aspiration. NOTE: Wear a protective glove when inducing vomiting by mechanical means. 4.2 Most important symptoms and effects, both acute and delayed See Section 11 4.3. Indication of any immediate medical attention and special treatment needed Treat symptomatically. Absorption of zinc compounds occurs in the small intestine. The metal is heavily protein bound. Elimination results primarily from faecal excretion. The usual measures for decontamination (Ipecac Syrup, lavage, charcoal or cathartics) may be administered, although patients usually have sufficient vomiting not to require them.